Ventas (VTR)
(Delayed Data from NYSE)
$43.61 USD
+0.05 (0.11%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $43.61 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Ventas (VTR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$50.71 | $60.00 | $46.00 | 16.41% |
Price Target
Based on short-term price targets offered by 17 analysts, the average price target for Ventas comes to $50.71. The forecasts range from a low of $46.00 to a high of $60.00. The average price target represents an increase of 16.41% from the last closing price of $43.56.
Analyst Price Targets (17)
Broker Rating
Ventas currently has an average brokerage recommendation (ABR) of 1.78 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 18 brokerage firms. The current ABR compares to an ABR of 1.78 a month ago based on 18 recommendations.
Of the 18 recommendations deriving the current ABR, 10 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 55.56% and 11.11% of all recommendations. A month ago, Strong Buy made up 55.56%, while Buy represented 11.11%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 10 | 11 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 6 | 6 | 6 | 8 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.78 | 1.78 | 1.78 | 1.90 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/9/2024 | Raymond James | Jonathan Hughes | Moderate Buy | Moderate Buy |
3/18/2024 | Evercore Partners | Stephen Sakwa | Hold | Strong Buy |
3/4/2024 | Scotiabank | Nicholas Yulico | Hold | Hold |
2/16/2024 | Edward D. Jones & Company | Kyle Sanders | Hold | Hold |
1/3/2024 | Mizuho SecuritiesUSA | Vikram Malhotra | Strong Buy | Strong Buy |
11/7/2023 | Wedbush Securities | Richard Anderson | Hold | Strong Buy |
10/18/2023 | KeyBanc Capital Markets | Austin Wurschmidt | Strong Buy | Strong Buy |
10/11/2023 | Exane BNP Paribas | Nathan D Crossett | Not Available | Strong Buy |
9/22/2023 | BMO Capital Markets | John P Kim | Not Available | Strong Buy |
8/16/2023 | Robert W. Baird & Co. | Wesley Golladay | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.78 |
ABR (Last week) | 1.78 |
# of Recs in ABR | 18 |
Average Target Price | $50.71 |
LT Growth Rate | 5.70% |
Industry | REIT and Equity Trust - Other |
Industry Rank by ABR | 150 of 252 |
Current Quarter EPS Est: | 0.75 |